Immunocore Holdings IMCR
NASDAQ IMCR
$30.85 +0.21 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Operating Margin (2021 - 2026)

Updated

Immunocore Holdings (IMCR) reported Operating Margin of -2.58% for Q2 2026, up 12.60 percentage points from -15.18% a year earlier but down 9.41 percentage points from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Operating Margin (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Immunocore Holdings' Operating Margin came in at -5.24%, up 7.80 percentage points year-over-year; for FY2025, it came in at -11.34%, up 11.38 percentage points from FY2024.

  • Operating Margin has increased for four consecutive years, with a five-year change of +274.88 percentage points (FY2020 to FY2025).
  • By year, Operating Margin came in at -22.71% in FY2024 (+1.20 pp), -23.91% in FY2023 (+5.74 pp), -29.66% in FY2022 (+448.87 pp) and -478.53% in FY2021 (-192.31 pp).
  • Five-year quarterly Operating Margin spans a low of -573.82% in Q4 2021 and a high of 14.98% in Q3 2022.
  • Year over year, Operating Margin has now increased in each of the last nine quarters, with an average year-over-year change of +10.43 percentage points over the last eight quarters.
  • The high point for year-over-year Operating Margin in five years was Q3 2022 (a gain of 537.43 percentage points); the low point was Q3 2023 (a drop of 36.79 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 6.82% (Q1 2026), -18.85% (Q4 2025) and -6.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Immunocore Holdings 1.58 Bn -1.90 Bn 114.84 Mn -2.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.58%
Mar 31, 2026 6.82%
Dec 31, 2025 -18.85%
Sep 30, 2025 -6.92%
Jun 30, 2025 -15.18%
Mar 31, 2025 -3.85%
Dec 31, 2024 -23.14%
Sep 30, 2024 -10.59%
Jun 30, 2024 -21.24%
Mar 31, 2024 -37.57%
Dec 31, 2023 -24.30%
Sep 30, 2023 -21.81%
Jun 30, 2023 -23.02%
Mar 31, 2023 -26.89%
Dec 31, 2022 -46.45%
Sep 30, 2022 14.98%
Jun 30, 2022 -51.43%
Dec 31, 2021 -573.82%
Sep 30, 2021 -522.45%
API Access

Immunocore Holdings Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=IMCR&period=max&api_key=YOUR_API_KEY